Services
Mission
The PathoQuest mission is to develop proprietary, rapid turn-around-time GMP Next Generation Sequencing (NGS) assays and bioinformatic approaches designed for biologics testing. These advancements accelerate adventitious agent detection and bioprocess characterization, and enables to replace the use of animals in biosafety testing. By enhancing biotesting methods and providing comprehensive biosafety services, we enable the safe and high-quality production of biopharmaceuticals.
SERVICES
Adventitious Virus Testing
Detection of viral contamination within the manufacturing process and beyond.
Identity Confirmation
Genetic characterization of viral and plasmid products for release.
Integration Site Analysis
Characterisation of genetic modifications for clone selection, genetic stability and lot release
Cell Line Characterization
Biosafety screening and stability testing of manufacturing cells.
HLA Genotyping
Characterizing and screening for novel and emerging cell therapies.
In Vivo Replacement
NGS as an ethical alternative to animals in biosafety testing and characterization.
Raw Material Testing
Screening of high-risk inputs such as animal products and media.
READ MORE
READ MORE
READ MORE
Contact us
U.S.
466 Devon Park Dr
Wayne, PA 19087
United States
E: contact@pathoquest.com
Sign up for our latest news
France
+33 (0)1 70 82 17 90
Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France
How can PathoQuest help?
U.S.
466 Devon Park Dr
Wayne, PA 19087
United States
France
+33 (0)1 70 82 17 90
Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France
E: contact@pathoquest.com
How can PathoQuest help?
Sign up for our latest news